BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37192041)

  • 21. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB; O'Ryan F
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.
    Shin JW; Kim JE; Huh KH; Yi WJ; Heo MS; Lee SS; Choi SC
    Sci Rep; 2024 Apr; 14(1):8744. PubMed ID: 38627515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
    Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
    J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.
    Otsuru M; Hayashida S; Morishita K; Murata M; Soutome S; Sasaki M; Takagi Y; Sumi M; Umeda M
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid.
    Wei LY; Kok SH; Lee YC; Chiu WY; Wang JJ; Cheng SJ; Chang HH; Lee JJ
    J Formos Med Assoc; 2021 Aug; 120(8):1572-1580. PubMed ID: 33309430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
    Neal TW; Schlieve T
    J Oral Maxillofac Surg; 2022 Oct; 80(10):1686-1690. PubMed ID: 35931181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
    Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
    Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis.
    Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
    Support Care Cancer; 2022 Mar; 30(3):2341-2348. PubMed ID: 34738163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
    Soutome S; Otsuru M; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Kojima Y; Sawada S; Iwai H; Umeda M; Saito T
    Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study.
    Otto S; Schnödt EM; Haidari S; Brunner TF; Aljohani S; Mosleh M; Ristow O; Troeltzsch M; Pautke C; Ehrenfeld M; Fliefel R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):519-526. PubMed ID: 33309263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
    Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
    Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of mandibular bone marrow using computed tomography texture analysis for detect stage 0 medication-related osteonecrosis of the jaw.
    Ito K; Muraoka H; Hirahara N; Sawada E; Hirohata S; Otsuka K; Okada S; Kaneda T
    Eur J Radiol; 2021 Dec; 145():110030. PubMed ID: 34798536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].
    Tröltzsch M; Tröltzsch M; Pautke C; Otto S
    HNO; 2022 Jul; 70(7):499-507. PubMed ID: 35050392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.
    Yamada SI; Kurita H; Kondo E; Suzuki S; Nishimaki F; Yoshimura N; Morioka M; Ishii S; Kamata T
    Clin Oral Investig; 2019 Aug; 23(8):3203-3211. PubMed ID: 30406491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients.
    Morishita K; Soutome S; Otsuru M; Hayashida S; Murata M; Sasaki M; Takagi Y; Sumi M; Umeda M
    Sci Rep; 2022 Jul; 12(1):11545. PubMed ID: 35799050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
    Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
    Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
    Ogawa R; Ogura I
    Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.